Events

Our calendar of events keeps our supporters informed of virtual and in-person support group meetings, webinars, fundraisers, walk-a-thons and more! We are happy to list your meeting, walk-a-thon, fundraiser, etc. The possibilities are endless. If you can think of it, you can do it. We are here to help you make your specific event a success. Let us know what we can do for you, be it providing you with materials to disperse, targeting a specific demographic for a mailing, or notifying the NAAF community on your upcoming event.

Send your event details to us at info@naaf.org to be included on the calendar. If you know of other events that would be of direct interest to NAAF supporters, please let us know about them as well.

NOTE: The National Alopecia Areata Foundation’s Support Group and Telephone Support Contact information on this and any other NAAF page, is intended for people with alopecia areata and their loved ones to easily find services in their area. Contacting individuals on this list directly to engage in commercial activities of any kind is strictly prohibited.

#Webinars

Upcoming Webinar

Virtual Event

Thursday, July 17, 2025 | 4:00 PM, PDT

JAK inhibitors in dermatology: Unpacking the boxed warning and long-term safety data

THURSDAY, JULY 17, 2025 4PM PST/ 6PM CST/ 7PM EST

The FDA’s approval of JAK inhibitors has transformed the treatment landscape for severe alopecia areata. These medications are also used across a range of autoimmune and inflammatory conditions, including several in dermatology. However, all JAK inhibitors carry a serious safety warning—also known as a box warning—highlighting the risk of significant side effects. 

But what does this warning really mean? In this webinar, board-certified dermatologist and clinical researcher Dr. Jennifer Soung will break down the science behind the FDA’s decision, explore the data that led to the boxed warning, and discuss what long-term safety studies now reveal. She’ll offer practical guidance on how to apply this evolving evidence when considering treatment options for alopecia areata—and help you weigh the risks, benefits, and context for using JAK inhibitors in dermatology today.